Gliadel

Active Ingredient(s): Carmustine, BCNU
FDA Approved: * September 23, 1996
Pharm Company: * MGI PHARMA INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gliadel Overview

Carmustine (bis-chloroethylnitrosourea, BCNU, BiCNU) is a medication used mainly for chemotherapy. It is a nitrogen mustard β-chloro-nitrosourea compound used as an alkylating agent. Contents 1 Description 2 Mechanism of action 3 Uses 4 Implants 5 Production 6 See also 7 References 8 External links Description Carmustine is an orange-yellow solid medication used mainly for chemotherapy. It is a nitrogen mustard β-chloro-nitrosourea compound. Mechanism of action As an alky...

Read more Gliadel Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carmustine

Recent Gliadel Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Gliadel: (2 results)

Sorted by National Drug Code

• 24338-050 Gliadel 7.7 mg/1 Intracavitary Wafer by Arbor Pharmaceuticals
• 62856-177 Gliadel 7.7 mg/1 Intracavitary Wafer by Eisai Inc.

Other drugs which contain Carmustine, BCNU or a similar ingredient: (2 results)

• BICNU Carmustine, BCNU
• CARMUSTINE, BCNU